<ul data-eligibleForWebStory="false"><li>FerryX is a startup focusing on developing next-generation probiotics to support gut health, specifically targeting chronic gut conditions like irritable bowel syndrome (IBS). They aim to provide relief where conventional products fail.</li><li>The unique solution offered by FerryX, named Ferrocalm, can remain active during gut inflammation, a capability most probiotics lack. This product has received positive feedback and life-changing reviews from customers.</li><li>FerryX is proud of the significant improvement in quality of life for consumers using Ferrocalm, with 76% experiencing better IBS symptoms within 8 weeks. They are currently seeking £1.5m investment to expand the brand and enhance profitability.</li><li>The startup acknowledges the support received from various entities in the Bristol and South-West ecosystem, such as the University of Bristol, SETsquared, Future Space, Tech South West, and Deepbridge Capital. More information about FerryX can be found on their website and social media platforms.</li></ul>

Silicon Gorge Profiles: Introducing FerryX

Discover more